Company NewsConference NewsPartner News Avance Clinical Announces Expanded eClinical Solutions for Biotech Clinical Trials at BioPharm America The leading Australian CRO for biotechs, and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner,…News EditorSeptember 22, 2020
Company News News: Jorgen Mold PhD, BSc (Hons) joins Avance Clinical as Scientific Affairs Specialist The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award…News EditorSeptember 13, 2020
Client NewsCompany News Avance Clinical Client Immunic, Inc. Announced Dosing of First Healthy Volunteer in Phase 1 Clinical Program of IMU-856, Targeting Restoration of Intestinal Barrier Function The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner…News EditorSeptember 4, 2020
Client NewsCompany News Avance Clinical Client Atossa Therapeutics Announces Enrollment and Dosing Completed in First Group of Healthy Participants in Clinical Study of AT-301 Nasal Spray Being Developed for Treatment of COVID-19 The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership…News EditorAugust 27, 2020
Other news Mike Watson Appointed Avance Clinical Director, Business Development, USA Mike Watson has joined Avance Clinical as Director, Business Development, USA. It is our pleasure…News EditorAugust 12, 2020